BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 27762634)

  • 1. Fatigue in facioscapulohumeral muscular dystrophy: a qualitative study of people's experiences.
    Schipper K; Bakker M; Abma T
    Disabil Rehabil; 2017 Sep; 39(18):1840-1846. PubMed ID: 27762634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. It's not just physical: a qualitative study regarding the illness experiences of people with facioscapulohumeral muscular dystrophy.
    Bakker M; Schipper K; Geurts AC; Abma TA
    Disabil Rehabil; 2017 May; 39(10):978-986. PubMed ID: 27211201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Both aerobic exercise and cognitive-behavioral therapy reduce chronic fatigue in FSHD: an RCT.
    Voet N; Bleijenberg G; Hendriks J; de Groot I; Padberg G; van Engelen B; Geurts A
    Neurology; 2014 Nov; 83(21):1914-22. PubMed ID: 25339206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of aerobic exercise training and cognitive behavioural therapy on reduction of chronic fatigue in patients with facioscapulohumeral dystrophy: protocol of the FACTS-2-FSHD trial.
    Voet NB; Bleijenberg G; Padberg GW; van Engelen BG; Geurts AC
    BMC Neurol; 2010 Jun; 10():56. PubMed ID: 20591139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of relatives on fatigue experienced by patients with facioscapulohumeral dystrophy, myotonic dystrophy and HMSN-I.
    Kalkman JS; Schillings ML; Zwarts MJ; van Engelen BG; Bleijenberg G
    Eur Neurol; 2006; 56(1):24-30. PubMed ID: 16914927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life and support needs in children, adolescents, and young adults with facioscapulohumeral dystrophy, a mixed-method study.
    Dijkstra JN; Rasing NB; Boon HTM; Altena-Rensen S; Cup EHC; Lanser A; Siemann IJ; van Engelen BG; Erasmus CE; Voermans NC
    Eur J Paediatr Neurol; 2024 May; 50():64-73. PubMed ID: 38692157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The facioscapulohumeral muscular dystrophy - health index: Italian validation of a disease-specific measure of symptomatic burden.
    Carraro E; Greco LC; Lizio A; Beretta M; Pozzi S; Casiraghi J; Becchiati S; Beshiri F; Frisoni MC; Iossa F; Heatwole C; Sansone V
    Disabil Rehabil; 2024 May; 46(10):2130-2137. PubMed ID: 37194629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upper limb function and activity in people with facioscapulohumeral muscular dystrophy: a web-based survey.
    Bergsma A; Cup EH; Janssen MM; Geurts AC; de Groot IJ
    Disabil Rehabil; 2017 Feb; 39(3):236-243. PubMed ID: 26942834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Balance and walking in facioscapulohumeral muscular dystrophy: multiperspective assessment.
    Aprile I; Padua L; Iosa M; Gilardi A; Bordieri C; Frusciante R; Russo G; Erra C; De Santis F; Ricci E
    Eur J Phys Rehabil Med; 2012 Sep; 48(3):393-402. PubMed ID: 22713540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Facing facial weakness: psychosocial outcomes of facial weakness and reduced facial function in facioscapulohumeral muscular dystrophy.
    van de Geest-Buit WA; Rasing NB; Mul K; Deenen JCW; Vincenten SCC; Siemann I; Lanser A; Groothuis JT; van Engelen BG; Custers JAE; Voermans NC
    Disabil Rehabil; 2023 Jul; 45(15):2507-2516. PubMed ID: 35815498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The development of a model of fatigue in neuromuscular disorders: a longitudinal study.
    Kalkman JS; Schillings ML; Zwarts MJ; van Engelen BG; Bleijenberg G
    J Psychosom Res; 2007 May; 62(5):571-9. PubMed ID: 17467412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of training and albuterol on pain and fatigue in facioscapulohumeral muscular dystrophy.
    van der Kooi EL; Kalkman JS; Lindeman E; Hendriks JC; van Engelen BG; Bleijenberg G; Padberg GW
    J Neurol; 2007 Jul; 254(7):931-40. PubMed ID: 17361345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experiences of patients with facioscapulohumeral dystrophy with facial weakness: a qualitative study.
    Sezer S; Cup EHC; Roets-Merken LM; Lanser A; Siemann I; Weikamp JG; Mul K; van Engelen BG; Satink T; Voermans NC
    Disabil Rehabil; 2022 Nov; 44(22):6775-6782. PubMed ID: 34529524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experiences with bariatric surgery in patients with facioscapulohumeral dystrophy and myotonic dystrophy type 1: A qualitative study.
    Abel EEDH; Cup EHC; Lanser A; Leclercq WKG; Raaphorst J; Padberg GW; Satink T; Voermans NC
    Neuromuscul Disord; 2018 Nov; 28(11):938-946. PubMed ID: 30342904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fitness and walking outcomes following aerobic and lower extremity strength training in facioscapulohumeral dystrophy: a case series.
    Prieur-Blanc N; Cotinat M; Vansteenkiste S; de Bovis Milhe V; Viton JM; Attarian S; Bensoussan L
    Int J Rehabil Res; 2024 Mar; 47(1):41-45. PubMed ID: 38323889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Balance and walking involvement in facioscapulohumeral dystrophy: a pilot study on the effects of custom lower limb orthoses.
    Aprile I; Bordieri C; Gilardi A; Lainieri Milazzo M; Russo G; De Santis F; Frusciante R; Iannaccone E; Erra C; Ricci E; Padua L
    Eur J Phys Rehabil Med; 2013 Apr; 49(2):169-78. PubMed ID: 23138679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upper Limb Rehabilitation in Facioscapulohumeral Muscular Dystrophy: A Patients' Perspective.
    Faux-Nightingale A; Kulshrestha R; Emery N; Pandyan A; Willis T; Philp F
    Arch Rehabil Res Clin Transl; 2021 Dec; 3(4):100157. PubMed ID: 34977539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medication adherence in patients with myotonic dystrophy and facioscapulohumeral muscular dystrophy.
    Fitzgerald BP; Conn KM; Smith J; Walker A; Parkhill AL; Hilbert JE; Luebbe EA; Moxley RT
    J Neurol; 2016 Dec; 263(12):2528-2537. PubMed ID: 27734165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Facioscapulohumeral dystrophy in children: design of a prospective, observational study on natural history, predictors and clinical impact (iFocus FSHD).
    Goselink RJ; Schreuder TH; Mul K; Voermans NC; Pelsma M; de Groot IJ; van Alfen N; Franck B; Theelen T; Lemmers RJ; Mah JK; van der Maarel SM; van Engelen BG; Erasmus CE
    BMC Neurol; 2016 Aug; 16():138. PubMed ID: 27530735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facioscapulohumeral Dystrophy in Childhood: A Nationwide Natural History Study.
    Goselink RJM; Schreuder THA; van Alfen N; de Groot IJM; Jansen M; Lemmers RJLF; van der Vliet PJ; van der Stoep N; Theelen T; Voermans NC; van der Maarel SM; van Engelen BGM; Erasmus CE
    Ann Neurol; 2018 Nov; 84(5):627-637. PubMed ID: 30179273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.